Ascentage Pharma to Present Data from Multiple Studies of Olverembatinib, Including the First Dataset from POLARIS-1 Study, at ASH 2025

Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated ...
TipRanks on MSN

Polaris Group’s Phase 3 Trial for Leiomyosarcoma: A Potential Game-Changer

Polaris Industries (($PII)) announced an update on their ongoing clinical study. Study Overview: Polaris Group is conducting a Phase 3 clinical ...
TipRanks on MSN

Polaris Industries’ Promising Study on ADI-PEG 20 for Liver Cancer

Polaris Industries (($PII)) announced an update on their ongoing clinical study. Study Overview: Polaris Industries is conducting a study titled A ...